Theresa Medina, MD, on Immunotherapies for Cutaneous Squamous Cell Carcinoma

Posted: Tuesday, October 8, 2024

Theresa Medina, MD, of the University of Colorado Cancer Center, Anschutz Medical Campus, explores how immunotherapies such as cemiplimab-rwlc and pembrolizumab are being used in the clinic to treat cutaneous squamous cell carcinoma and who might represent the ideal candidate (particularly those who are not candidates for radiation therapy).

---